Get access to our best features
Get access to our best features
Published 1 year ago

New Alzheimer's drug hailed for results but comes with risks

Summary by Ground News
Lecanemab slowed cognitive decline by 27 percent across an 18-month period. The results were broadly welcomed by researchers and campaigners for Alzheimer's. But the drug can have serious side effects, including brain bleeds and swelling. Longer trials will be needed to be sure the benefits of this treatment outweigh the risks, experts say.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 75% of the sources are Center
75% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)